Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edaravone dexborneol for ischemic stroke after thrombectomy
NCT04667637Phase 2Completed
- Start
- Feb 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of edaravone dexborneol in ischemic stroke. Started Feb 2021; status: completed.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT04667637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04667637.